It has become increasingly clear that new approach methodologies (NAMs)—when combined with knowledge of the pathway, results of pharmacology studies, and other relevant data—may offer ways to reduce animal testing.
Similar Posts
Scientific Protein Laboratories, LLC – 712578 – 10/10/2025
CGMP/Active Pharmaceutical Ingredient (API)/AdulteratedZydus Lifesciences Limited – 9/5/2025
Zydus Lifesciences Limited – 9/5/2025. Country: India. Record Type: 483FDA Launches Green List to Protect Americans from Illegal Imported GLP-1 Drug Ingredients
The U.S. Food and Drug Administration today established a “green list” import alert to help stop potentially dangerous GLP-1 (glucagon-like peptide-1) active pharmaceutical ingredients (APIs) from unverified foreign sources from entering the U.S. market.Infusion Pump Correction: Baxter Issues Correction for Novum IQ Large Volume Pumps
This communication is part of the Communications Pilot to Enhance the Medical Device Recall ProgramA.S.K. Foods, LLC Issues Allergy Alert on Undeclared Soy in Publix Rice & Pigeon Peas
A.S.K. Foods, LLC of Palmyra, PA is recalling select 32 oz. containers of Publix Rice & Pigeon Peas because it contains undeclared soy. People who have an allergy or severe sensitivity to soy run the risk of serious or life-threatening allergic reaction if they consume this product.Cefiderocol Injection
Cefiderocol Injection – FDA Identified Interpretive Criteria